| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008763 | Annals of Allergy, Asthma & Immunology | 2005 | 6 Pages |
Abstract
Olopatadine nasal spray (0.4% and 0.6%) provided statistically significant improvements in allergic rhinitis symptoms compared with placebo regarding TNSSs and individual symptoms, including congestion, itchy and runny nose, sneezing, and itchy and watery eyes, in patients with SAR to mountain cedar. Olopatadine nasal spray administered twice daily was safe and well tolerated in adolescents and adults.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul H. MD, Frank C. MD, Niran J. MD, Julius H. MD, Dale MD, Bradley F. MD, Peter S. MD, G.Michael PhD, Michael J. PhD, Margaret BA, Darell PhD, Lewis H. PhD,